ZNF575 Activators
Items 1 to 10 of 24 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
Inhibits CDK4/6 involved in cell cycle regulation, which can lead to reduced activity of ZNF575 by limiting its availability in the proliferating cells. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol is an activator of SIRT1, a protein deacetylase. ZNF575, being a zinc finger protein, can bind to DNA and regulate its transcription. SIRT1 activation by Resveratrol can enhance histone deacetylation, leading to changes in chromatin structure that may enhance the DNA-binding activity of ZNF575. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $67.00 $306.00 | 2 | |
Inhibits cyclin-dependent kinases, possibly resulting in decreased phosphorylation of ZNF575, thereby reducing its activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor. By inhibiting HDACs, it prevents the deacetylation of histones, leading to a more relaxed chromatin structure that may enhance the DNA-binding activity of ZNF575. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
SAHA is a histone deacetylase (HDAC) inhibitor. By inhibiting HDACs, it prevents the deacetylation of histones, leading to a more relaxed chromatin structure that may enhance the DNA-binding activity of ZNF575. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Targets CDKs, potentially leading to decreased phosphorylation and subsequent activity of ZNF575. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which could lead to reduced activity of ZNF575 due to inhibited phosphorylation signaling pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is a short-chain fatty acid that functions as an inhibitor of histone deacetylases (HDACs). By inhibiting HDACs, it can induce a more relaxed chromatin structure that may enhance the DNA-binding activity of ZNF575. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-aza-2'-deoxycytidine is a DNA methyltransferase inhibitor. By inhibiting DNA methylation, it can create a more open chromatin structure that may enhance the DNA-binding activity of ZNF575. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, potentially decreasing ZNF575 activity by affecting stress response signaling pathways it may be involved in. | ||||||